ArticleInternational journal of cancer2022

Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study.

Johnny R Östman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.